Osaic Holdings’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Sell |
131,247
-84,527
| -39% | -$248K | ﹤0.01% | 3036 |
|
|
2025
Q1 | $481K | Buy |
215,774
+83,760
| +63% | +$187K | ﹤0.01% | 2910 |
|
|
2024
Q4 | $387K | Buy |
132,014
+27,760
| +27% | +$81.3K | ﹤0.01% | 3023 |
|
|
2024
Q3 | $271K | Sell |
104,254
-2,223
| -2% | -$5.78K | ﹤0.01% | 3400 |
|
|
2024
Q2 | $315K | Buy |
106,477
+1,630
| +2% | +$4.83K | ﹤0.01% | 3165 |
|
|
2024
Q1 | $475K | Buy |
104,847
+2,689
| +3% | +$12.2K | ﹤0.01% | 2979 |
|
|
2023
Q4 | $583K | Sell |
102,158
-95,633
| -48% | -$546K | ﹤0.01% | 3028 |
|
|
2023
Q3 | $910K | Buy |
197,791
+106,970
| +118% | +$492K | ﹤0.01% | 2711 |
|
|
2023
Q2 | $587K | Buy |
90,821
+6,371
| +8% | +$41.2K | ﹤0.01% | 3009 |
|
|
2023
Q1 | $637K | Buy |
84,450
+9,784
| +13% | +$73.8K | ﹤0.01% | 2881 |
|
|
2022
Q4 | $757K | Buy |
74,666
+4,799
| +7% | +$48.6K | ﹤0.01% | 2642 |
|
|
2022
Q3 | $691K | Buy |
69,867
+21,336
| +44% | +$211K | ﹤0.01% | 2573 |
|
|
2022
Q2 | $517K | Buy |
48,531
+7,832
| +19% | +$83.4K | ﹤0.01% | 2889 |
|
|
2022
Q1 | $397K | Buy |
40,699
+13,877
| +52% | +$135K | ﹤0.01% | 3437 |
|
|
2021
Q4 | $383K | Buy |
26,822
+13,738
| +105% | +$196K | ﹤0.01% | 3325 |
|
|
2021
Q3 | $262K | Buy |
13,084
+6,987
| +115% | +$140K | ﹤0.01% | 3654 |
|
|
2021
Q2 | $133K | Buy |
6,097
+1,526
| +33% | +$33.3K | ﹤0.01% | 4229 |
|
|
2021
Q1 | $155K | Buy |
4,571
+3,121
| +215% | +$106K | ﹤0.01% | 3971 |
|
|
2020
Q4 | $58K | Buy |
+1,450
| New | +$58K | ﹤0.01% | 4440 |
|